Cargando…

Virotherapy in Cancer

New cancer therapies with novel mechanisms and functions are needed to treatpatients with different cancers. Virotherapy is a good scenario for such treatment. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruct...

Descripción completa

Detalles Bibliográficos
Autor principal: Motalleb, Gholamreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Research Center, Shahid Beheshti University of Medical Sciences 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142919/
https://www.ncbi.nlm.nih.gov/pubmed/25250118
_version_ 1782331834530529280
author Motalleb, Gholamreza
author_facet Motalleb, Gholamreza
author_sort Motalleb, Gholamreza
collection PubMed
description New cancer therapies with novel mechanisms and functions are needed to treatpatients with different cancers. Virotherapy is a good scenario for such treatment. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms. Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its self-perpetuating nature provides an ideal platform for therapeutic transgenic insertion. In this review article, a variety of oncolytic viruses in cancer gene therapy will be described.
format Online
Article
Text
id pubmed-4142919
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Cancer Research Center, Shahid Beheshti University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-41429192014-09-23 Virotherapy in Cancer Motalleb, Gholamreza Iran J Cancer Prev Review Article New cancer therapies with novel mechanisms and functions are needed to treatpatients with different cancers. Virotherapy is a good scenario for such treatment. The advantages of virotherapy include the potential lack of cross resistance with standard therapies and the ability to cause tumor destruction by numerous mechanisms. Oncolytic virus not only possesses unique mechanisms of action that are distinct from other treatment modalities, its self-perpetuating nature provides an ideal platform for therapeutic transgenic insertion. In this review article, a variety of oncolytic viruses in cancer gene therapy will be described. Cancer Research Center, Shahid Beheshti University of Medical Sciences 2013 /pmc/articles/PMC4142919/ /pubmed/25250118 Text en © 2014 Cancer Research Center, Shahid Beheshti University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Review Article
Motalleb, Gholamreza
Virotherapy in Cancer
title Virotherapy in Cancer
title_full Virotherapy in Cancer
title_fullStr Virotherapy in Cancer
title_full_unstemmed Virotherapy in Cancer
title_short Virotherapy in Cancer
title_sort virotherapy in cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4142919/
https://www.ncbi.nlm.nih.gov/pubmed/25250118
work_keys_str_mv AT motallebgholamreza virotherapyincancer